There was a statistically significant relationship between survey and PD-L1 expression of >5% PD-L1 positivity in tumor-infiltrating lymphocites or tumor in a study using anti-PD-L1 sp263 clone in cSCC cases in the head and neck region [47]. This evidence concerns the gene CD274 and neoplasm.